Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3443.4
(1.87%)
INR 3443.4
(1.87%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 31.83 Billion INR | -34.51% |
| 2022 | 48.6 Billion INR | 32.38% |
| 2021 | 36.71 Billion INR | -14.65% |
| 2020 | 43.01 Billion INR | -16.93% |
| 2019 | 51.78 Billion INR | -4.98% |
| 2018 | 54.49 Billion INR | -12.41% |
| 2017 | 62.21 Billion INR | 178.85% |
| 2016 | 22.31 Billion INR | 7.8% |
| 2015 | 20.69 Billion INR | -13.87% |
| 2014 | 24.02 Billion INR | 561.26% |
| 2013 | 3.63 Billion INR | 440.01% |
| 2012 | 672.9 Million INR | 171.16% |
| 2011 | -945.6 Million INR | -9.71% |
| 2010 | -861.92 Million INR | -164.29% |
| 2009 | 1.34 Billion INR | -46.93% |
| 2008 | 2.52 Billion INR | 4.62% |
| 2007 | 2.41 Billion INR | -13.2% |
| 2006 | 2.78 Billion INR | 54.17% |
| 2005 | 1.8 Billion INR | -10.55% |
| 2004 | 2.01 Billion INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 19.02 Billion INR | 0.0% |
| 2023 FY | 31.83 Billion INR | -34.51% |
| 2023 Q2 | 39.51 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 31.83 Billion INR | 0.0% |
| 2022 Q2 | 37.4 Billion INR | 0.0% |
| 2022 FY | 48.6 Billion INR | 32.38% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 48.6 Billion INR | 0.0% |
| 2021 FY | 36.71 Billion INR | -14.65% |
| 2021 Q2 | 40.72 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 36.71 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 34.85 Billion INR | 0.0% |
| 2020 FY | 43.01 Billion INR | -16.93% |
| 2020 Q4 | 43.01 Billion INR | 0.0% |
| 2019 Q4 | 51.78 Billion INR | 0.0% |
| 2019 FY | 51.78 Billion INR | -4.98% |
| 2019 Q2 | 38.94 Billion INR | 0.0% |
| 2018 Q4 | 54.49 Billion INR | 0.0% |
| 2018 Q2 | 51.81 Billion INR | 0.0% |
| 2018 FY | 54.49 Billion INR | -12.41% |
| 2017 FY | 62.21 Billion INR | 178.85% |
| 2017 Q4 | 62.21 Billion INR | 0.0% |
| 2017 Q2 | 20.96 Billion INR | 0.0% |
| 2016 Q4 | 22.31 Billion INR | 0.0% |
| 2016 FY | 22.31 Billion INR | 7.8% |
| 2016 Q2 | 17.37 Billion INR | 0.0% |
| 2015 Q4 | 20.69 Billion INR | 0.0% |
| 2015 Q2 | 16.05 Billion INR | 0.0% |
| 2015 FY | 20.69 Billion INR | -13.87% |
| 2014 Q2 | 16.6 Billion INR | 0.0% |
| 2014 Q4 | 24.02 Billion INR | 0.0% |
| 2014 FY | 24.02 Billion INR | 561.26% |
| 2013 Q2 | 960 Million INR | 0.0% |
| 2013 Q4 | 3.63 Billion INR | 0.0% |
| 2013 FY | 3.63 Billion INR | 440.01% |
| 2012 Q4 | 672.9 Million INR | 0.0% |
| 2012 FY | 672.9 Million INR | 171.16% |
| 2011 Q4 | -945.6 Million INR | 0.0% |
| 2011 FY | -945.6 Million INR | -9.71% |
| 2010 FY | -861.92 Million INR | -164.29% |
| 2009 FY | 1.34 Billion INR | -46.93% |
| 2008 FY | 2.52 Billion INR | 4.62% |
| 2007 FY | 2.41 Billion INR | -13.2% |
| 2006 FY | 2.78 Billion INR | 54.17% |
| 2005 FY | 1.8 Billion INR | -10.55% |
| 2004 FY | 2.01 Billion INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | -954.9 Million INR | 3433.333% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 12893.82% |
| Sigachi Industries Limited | 859.94 Million INR | -3601.382% |
| Bal Pharma Limited | 1.26 Billion INR | -2419.071% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 866.424% |
| Medico Remedies Limited | 78.67 Million INR | -40356.55% |
| Lasa Supergenerics Limited | 205.79 Million INR | -15366.547% |
| Venus Remedies Limited | -267.7 Million INR | 11990.176% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 3479.698% |
| Alpa Laboratories Limited | 35.36 Million INR | -89909.332% |
| Nectar Lifesciences Limited | 6.15 Billion INR | -416.947% |
| Shilpa Medicare Limited | 9.06 Billion INR | -250.955% |
| Aarti Drugs Limited | 5.54 Billion INR | -473.679% |
| Lupin Limited | 17.19 Billion INR | -85.141% |
| Aurobindo Pharma Limited | 3.69 Billion INR | -761.831% |
| Zydus Lifesciences Limited | 3.91 Billion INR | -713.65% |
| Windlas Biotech Limited | -273.04 Million INR | 11757.633% |
| Suven Life Sciences Limited | -1.63 Billion INR | 2049.534% |
| Eris Lifesciences Limited | 13.8 Billion INR | -130.545% |
| Valiant Laboratories Limited | -295.03 Million INR | 10888.66% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -1028.243% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | -217.38% |
| Ipca Laboratories Limited | 11.41 Billion INR | -178.839% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 2849.293% |
| Achyut Healthcare Limited | -3.74 Million INR | 849806.353% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 143.922% |
| Bajaj HealthCare Limited | 3.29 Billion INR | -864.851% |
| RPG Life Sciences Limited | -364.7 Million INR | 8827.721% |
| Mankind Pharma Limited | -9.9 Billion INR | 421.256% |
| Laurus Labs Limited | 24.38 Billion INR | -30.533% |
| Piramal Pharma Limited | 42.27 Billion INR | 24.709% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -68779.704% |
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | -723.353% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 842.779% |
| Unichem Laboratories Limited | 931.91 Million INR | -3315.544% |
| Sequent Scientific Limited | 4.17 Billion INR | -661.733% |
| Novartis India Limited | -5.89 Billion INR | 640.307% |
| Wanbury Limited | 1.1 Billion INR | -2778.264% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -21855.358% |
| Wockhardt Limited | 18.27 Billion INR | -74.22% |
| Themis Medicare Limited | 764.96 Million INR | -4060.991% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 2390.043% |
| Jubilant Pharmova Limited | 27.07 Billion INR | -17.575% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 1219.726% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | -146.496% |
| Divi's Laboratories Limited | -39.77 Billion INR | 180.035% |
| NATCO Pharma Limited | -5.81 Billion INR | 647.189% |
| Gufic Biosciences Limited | 3.19 Billion INR | -896.457% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 2990.221% |
| Ind-Swift Limited | 9.5 Billion INR | -234.75% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 1455.622% |
| FDC Limited | -57.75 Million INR | 55214.974% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -1546.731% |
| Granules India Limited | 9.28 Billion INR | -242.745% |
| Medicamen Biotech Limited | 160.31 Million INR | -19754.537% |
| Alkem Laboratories Limited | -1.6 Billion INR | 2077.756% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 735.02% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 172657.736% |
| Brooks Laboratories Limited | 49.48 Million INR | -64222.522% |
| Megasoft Limited | 1.28 Billion INR | -2375.979% |
| ZIM Laboratories Limited | 983.6 Million INR | -3136.058% |
| Strides Pharma Science Limited | 23.25 Billion INR | -36.862% |
| Neuland Laboratories Limited | -214.05 Million INR | 14969.802% |
| Morepen Laboratories Limited | -231.17 Million INR | 13868.849% |
| Hikal Limited | 7.96 Billion INR | -299.523% |
| Indoco Remedies Limited | 6.47 Billion INR | -391.484% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -1118.653% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -26416.382% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -3161.902% |
| Hester Biosciences Limited | 2.29 Billion INR | -1289.507% |